<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Prostate Health News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/prostate_health/</link>
		<description>Latest research news on prostate health. Find out about prostate cancer symptoms, enlarged prostate and other prostate problems.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 22:38:54 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 22:38:54 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Prostate Health News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/prostate_health/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/prostate_health" /><feedburner:info uri="sciencedaily/health_medicine/prostate_health" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/prostate_health</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Low vitamin D predicts aggressive prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/XlP0jy6s3Tg/160301131117.htm</link>
			<description>A new study provides a major link between low levels of vitamin D and aggressive prostate cancer. Research showed deficient vitamin D blood levels in men can predict aggressive prostate cancer identified at the time of surgery. The finding is important because it can offer guidance to men and their doctors who may be considering active surveillance, in which they monitor the cancer rather than remove the prostate&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/XlP0jy6s3Tg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 13:11:17 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301131117.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301131117.htm</feedburner:origLink></item>
		<item>
			<title>Precision oncology could be tailor-made for metastatic prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/58YmFnljeLw/160229135146.htm</link>
			<description>Metastatic prostate cancer, where better therapeutic strategies are desperately needed, appears to be tailor-made for precision oncology, according to a new study. Researchers found that a single metastasis within an individual patient can provide consistent molecular information to help guide therapy in metastatic prostate cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/58YmFnljeLw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160229135146.jpg" height="200" width="300" />
			<pubDate>Mon, 29 Feb 2016 13:51:46 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229135146.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229135146.htm</feedburner:origLink></item>
		<item>
			<title>Many prostate cancer patients saved from unnecessary treatments and side effects</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/gOGB5Ys5krk/160229135133.htm</link>
			<description>Men with slow-growing prostate cancer are increasingly avoiding unnecessary and potentially harmful treatment in favor of an approach called active surveillance -- monitoring the cancer with regular tests and treating it only if it changes to a higher risk form.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/gOGB5Ys5krk" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160229135133.jpg" height="205" width="300" />
			<pubDate>Mon, 29 Feb 2016 13:51:33 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229135133.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229135133.htm</feedburner:origLink></item>
		<item>
			<title>Normal stem cells linked to aggressive prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/R-CgjJZfWx0/160229081853.htm</link>
			<description>A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer, report scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/R-CgjJZfWx0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 08:18:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229081853.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229081853.htm</feedburner:origLink></item>
		<item>
			<title>Light reflectance technique improves ability to remove prostate cancer during surgery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/FX1E7gGocGU/160226144142.htm</link>
			<description>Researchers have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time tissue analysis during prostate cancer surgery.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/FX1E7gGocGU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 14:41:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226144142.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226144142.htm</feedburner:origLink></item>
		<item>
			<title>Researchers work to decipher genetic data in hunt for new prostate cancer treatments</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/Bf1d-d0346Q/160219111515.htm</link>
			<description>Researchers are working on new approaches to deciphering genetic data that may lead to new, more targeted prostate cancer treatments. Prostate cancer affects one in seven men in the United States.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/Bf1d-d0346Q" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 19 Feb 2016 11:15:15 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160219111515.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160219111515.htm</feedburner:origLink></item>
		<item>
			<title>Low-risk prostate cancer best managed with active surveillance, according to new recommendations</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/cXCB-eYBeZ0/160217183429.htm</link>
			<description>A new report details guidelines for the active surveillance of men with low-risk prostate cancer. The report recommends active surveillance for most patients with low-risk, localized prostate cancer, using regular monitoring with the prostate-specific antigen, or PSA, blood test, prostate biopsy and digital rectal exam. However, it does list exceptions for younger patients, African American patients, and those with high-volume cancer in the prostate â because these patients are more likely to have cancer progression with active surveillance.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/cXCB-eYBeZ0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 18:34:29 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217183429.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217183429.htm</feedburner:origLink></item>
		<item>
			<title>Synthetic plant hormones shut down DNA repair in cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/3H0oPvE06gw/160216181055.htm</link>
			<description>Two drugs that mimic a common plant hormone effectively cause DNA damage and turn off a major DNA repair mechanism, suggesting their potential use as an anti-cancer therapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/3H0oPvE06gw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 18:10:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216181055.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216181055.htm</feedburner:origLink></item>
		<item>
			<title>New milestone for device that can 'smell' prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/yL7w4x0MgjI/160211082257.htm</link>
			<description>An important milestone has been reached towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/yL7w4x0MgjI" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160211082257.jpg" height="202" width="300" />
			<pubDate>Thu, 11 Feb 2016 08:22:57 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211082257.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211082257.htm</feedburner:origLink></item>
		<item>
			<title>Prostate cancer survivors' risk of heart disease studied</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/PZvoh56aY_4/160210134946.htm</link>
			<description>A cardio-oncology program is focusing on modulating the risk factors for cardiovascular disease in men, especially those receiving androgen deprivation therapy (ADT) to treat their prostate cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/PZvoh56aY_4" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160210134946.jpg" height="157" width="300" />
			<pubDate>Wed, 10 Feb 2016 13:49:46 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160210134946.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160210134946.htm</feedburner:origLink></item>
		<item>
			<title>Difference in PSA testing among urologist, primary care physician visits</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/Okxh0vc9hTo/160208123837.htm</link>
			<description>Declines in prostate-specific antigen (PSA) testing differed among urologist and primary care physician visits in a study that compared testing before and after a 2011 recommendation from the US Preventive Services Task Force against PSA screening for all men, according to an article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/Okxh0vc9hTo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 08 Feb 2016 12:38:37 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208123837.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208123837.htm</feedburner:origLink></item>
		<item>
			<title>New class of drug slows growth of castration-resistant prostate cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/i1IprgPicPE/160129131647.htm</link>
			<description>Sphingosine kinase inhibitors are a new category of drugs that act on specific enzymes involved in sphingolipid metabolism to reduce the formation of a pro-cancer, pro-inflammatory lipid signaling molecule known as sphingosine-1 phosphate (S1P). Preclinical studies showed that a first-in-class sphingosine kinase 2 inhibitor slowed growth of aggressive prostate cancer cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/i1IprgPicPE" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/01/160129131647.jpg" height="320" width="300" />
			<pubDate>Fri, 29 Jan 2016 13:16:47 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160129131647.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160129131647.htm</feedburner:origLink></item>
		<item>
			<title>Better way to image metastatic prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/8-Shmf3O4kw/160127132622.htm</link>
			<description>A recent study shows in a prospective, systematic manner that a PET/CT scan, using the radiotracer F-18-DCFBC to target prostate-specific membrane antigen (PSMA), is significantly more effective at detecting metastatic prostate cancer than conventional imaging methods.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/8-Shmf3O4kw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 27 Jan 2016 13:26:22 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160127132622.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160127132622.htm</feedburner:origLink></item>
		<item>
			<title>New tool to determine the risk of prostate cancer death</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/_i47Z0y9NZQ/160127115510.htm</link>
			<description>A new prognostic biomarker has been identified by researchers: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/_i47Z0y9NZQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 27 Jan 2016 11:55:10 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160127115510.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160127115510.htm</feedburner:origLink></item>
		<item>
			<title>Nonrecommended screenings for prostate, breast cancer in older individuals</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/Ir4kX09Umso/160121130338.htm</link>
			<description>An estimated 15.7 percent of individuals 65 or older may have received nonrecommended screenings for prostate and breast cancers because they had limited life expectancies of less than 10 years, according to a new article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/Ir4kX09Umso" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 21 Jan 2016 13:03:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160121130338.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160121130338.htm</feedburner:origLink></item>
		<item>
			<title>Imaging test accurately detects extent of prostate cancer in patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/B_etELvnWac/160120114142.htm</link>
			<description>The method that researchers have developed to image the prostate appears to be much better at detecting prostate cancer than any other test -- radiographical, biopsy or blood -- in use today.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/B_etELvnWac" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 20 Jan 2016 11:41:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160120114142.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160120114142.htm</feedburner:origLink></item>
		<item>
			<title>Why prostate cancer is more aggressive in obese patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/ObLU0uF8ix0/160112125531.htm</link>
			<description>Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers have recently elucidated one of these mechanisms in prostate cancer, one of the most common cancers in men: in obese patients, the adipose tissue surrounding the prostate gland facilitates the propagation of tumor cells outside the prostate.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/ObLU0uF8ix0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/01/160112125531.jpg" height="314" width="300" />
			<pubDate>Tue, 12 Jan 2016 12:55:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160112125531.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160112125531.htm</feedburner:origLink></item>
		<item>
			<title>Cancer-killing proteins destroy tumor cells in bloodstream</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/RV1IGsXQDTc/160112113612.htm</link>
			<description>Potent cancer-killing proteins that can travel by white blood cells to kill tumors have been discovered in the bloodstream of mice with metastatic prostate cancer. In the study, prostate cancer cells were implanted into the prostate of male mice to let the tumors grow. The researchers found that secondary tumors were prevented by the treatment and that the primary tumor shrunk in size.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/RV1IGsXQDTc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 12 Jan 2016 11:36:12 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160112113612.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160112113612.htm</feedburner:origLink></item>
		<item>
			<title>Novel gene alteration associates with aggressive prostate cancer in African American men</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/9hua4bvfSbg/160111153220.htm</link>
			<description>It is well established that prostate cancer is more prevalent in African American men when compared to men of other ethnicities. There has been a premise that a combination of genetics, lifestyle, nutritional and medical access reasons led to the significant statistical difference. However, in a new study, researchers found some distinct genomic variations that also could be to blame.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/9hua4bvfSbg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 11 Jan 2016 15:32:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160111153220.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160111153220.htm</feedburner:origLink></item>
		<item>
			<title>Most men not getting prostate cancer screening, treatment information they need</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/rwLVy2f3QWg/160106220514.htm</link>
			<description>Men and their health providers are not having important discussions when it comes to prostate cancer screening and treatment, new research has discovered.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/rwLVy2f3QWg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 06 Jan 2016 22:05:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160106220514.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160106220514.htm</feedburner:origLink></item>
		<item>
			<title>Exercise could work as treatment for prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/DpIXBtCxYh4/160105223945.htm</link>
			<description>A new study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer. Prostate cancer that has not spread is sometimes treated with surgery or radiotherapy. But this can have side-effects so many men opt for active surveillance instead, which involves monitoring the disease. All the men in the new study are and will remain on active surveillance -- and they will also be closely monitored as part of the study itself.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/DpIXBtCxYh4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 05 Jan 2016 22:39:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160105223945.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160105223945.htm</feedburner:origLink></item>
		<item>
			<title>Screening male kidney transplant candidates for prostate cancer may do more harm than good</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/bYt8LXAE3B4/151223141142.htm</link>
			<description>Among male kidney transplant candidates, prostate cancer screening was not associated with improved patient survival after transplantation, a new report concludes. Screening increased the time to listing and transplantation for candidates under 70 years old with elevated prostate specific antigen levels. Compared with candidates who were not screened, screened candidates had a reduced likelihood of receiving a transplant regardless of their screening results.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/bYt8LXAE3B4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 23 Dec 2015 14:11:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151223141142.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151223141142.htm</feedburner:origLink></item>
		<item>
			<title>Immune suppressor cells identified for advanced prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/l0XgBptvdIs/151221133834.htm</link>
			<description>Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/l0XgBptvdIs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 21 Dec 2015 13:38:34 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151221133834.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151221133834.htm</feedburner:origLink></item>
		<item>
			<title>Prostate cancer discovery may make it easier to kill cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/natQo4GH48w/151218084505.htm</link>
			<description>A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, report scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/natQo4GH48w" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 18 Dec 2015 08:45:05 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151218084505.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151218084505.htm</feedburner:origLink></item>
		<item>
			<title>New 'condensed' grading system shown accurate for predicting prostate cancer outcomes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/-5KM0qrnXNI/151216105659.htm</link>
			<description>Using information gleaned from more than 20,000 men, researchers have affirmed the value of their alternative system for assessing the likelihood of growth and spread of prostate cancer. The new grading system, they say, is not only easier to use and understand, but also more accurate than the long-used Gleason grading system, and it has the potential to substantially reduce overtreatment of low-risk tumors.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/-5KM0qrnXNI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 16 Dec 2015 10:56:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151216105659.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151216105659.htm</feedburner:origLink></item>
		<item>
			<title>Survival rates for patients with prostate cancer better with surgery vrs radiotherapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/5UfMrWmi97E/151215091405.htm</link>
			<description>A rigorous evaluation of survival rates has shown that cancer patients with localised prostate cancer -- the most common form of prostate cancer -- have a better chance of survival if treated by surgery than by radiotherapy. This is the most robust analysis (meta-analysis) to date of published literature comparing surgery and radiotherapy for localized prostate cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/5UfMrWmi97E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 15 Dec 2015 09:14:05 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151215091405.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151215091405.htm</feedburner:origLink></item>
		<item>
			<title>Suicide gene therapy kills prostate tumor cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/a4KuB0G1cK4/151212051759.htm</link>
			<description>Results from a long-term clinical trial conducted by cancer researchers show that combining radiation treatment with 'suicide gene therapy' provides a safe and effective one-two punch against the disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/a4KuB0G1cK4" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151212051759.jpg" height="162" width="300" />
			<pubDate>Sat, 12 Dec 2015 05:17:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151212051759.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151212051759.htm</feedburner:origLink></item>
		<item>
			<title>Combined imaging modalities may change cancer management</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/piGKW4R9Zus/151210140514.htm</link>
			<description>PET/CT and whole-body MRI detect extraskeletal disease that may change the management of high-risk breast and prostate cancer patients, according to a recent study. In addition, the combined administration of F-18 sodium fluoride (NaF) and F-18 fluorodeoxyglucose (FDG) in a single PET/CT scan showed significantly higher sensitivity and accuracy than alternative methods for the detection of skeletal lesions.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/piGKW4R9Zus" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 10 Dec 2015 14:05:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151210140514.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151210140514.htm</feedburner:origLink></item>
		<item>
			<title>Controversial prostate cancer screening can be improved by repeating abnormal tests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/TCoEcT3fDsU/151210124555.htm</link>
			<description>For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned because it leads to many unnecessary biopsies. Now, a new study shows that simply repeating abnormal PSA tests dramatically reduces unnecessary biopsies.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/TCoEcT3fDsU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 10 Dec 2015 12:45:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151210124555.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151210124555.htm</feedburner:origLink></item>
		<item>
			<title>Testosterone-lowering therapy for prostate cancer may increase Alzheimer's risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/WsF-Ertoghk/151207163940.htm</link>
			<description>Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimerâs disease in the years that followed than those who didnât undergo the therapy, an analysis of medical records from two large hospital systems has shown.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/WsF-Ertoghk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 07 Dec 2015 16:39:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151207163940.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151207163940.htm</feedburner:origLink></item>
		<item>
			<title>Men who forgo aggressive treatment for prostate cancer don't receive appropriate monitoring</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/UpxnUMWUO6E/151201093602.htm</link>
			<description>An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance -- closely monitoring their cancer -- rather than aggressive treatment to avoid the debilitating potential side effects of surgery and radiation.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/UpxnUMWUO6E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Dec 2015 09:36:02 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151201093602.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151201093602.htm</feedburner:origLink></item>
		<item>
			<title>Promising drug combination for advanced prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/EayWBCUqlGQ/151125104940.htm</link>
			<description>A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/EayWBCUqlGQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 25 Nov 2015 10:49:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151125104940.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151125104940.htm</feedburner:origLink></item>
		<item>
			<title>Soccer strengthens bones of men with prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/zLJaCBxbD-k/151123202804.htm</link>
			<description>Men with prostate cancer run the risk of brittle bones as a side-effect of their treatment. But one hour's football training a few times a week counters many of the negative effects of the treatment, according to scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/zLJaCBxbD-k" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151123202804.jpg" height="200" width="300" />
			<pubDate>Mon, 23 Nov 2015 20:28:04 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151123202804.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151123202804.htm</feedburner:origLink></item>
		<item>
			<title>Working up a sweat may protect men from lethal prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/ftzc7nwUgkQ/151118094339.htm</link>
			<description>A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/ftzc7nwUgkQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 18 Nov 2015 09:43:39 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151118094339.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151118094339.htm</feedburner:origLink></item>
		<item>
			<title>Bone protein inhibits prostate cancer invasion, scientists find</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/g7lI5Dj0pIk/151117145052.htm</link>
			<description>A secreted protein predominantly expressed in bone inhibits prostate cancer metastasis to bone, new research shows. Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer-related deaths among men in the United States. If detected at early stages the prognosis is quite favorable; however, aggressive forms of metastatic prostate cancer spread primarily to the skeleton.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/g7lI5Dj0pIk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 17 Nov 2015 14:50:52 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151117145052.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151117145052.htm</feedburner:origLink></item>
		<item>
			<title>Prostate cancer screening drops dramatically in middle-aged men</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/Le6LYLj7DgI/151117130134.htm</link>
			<description>Prostate-specific antigen testing has dropped significantly in middle-aged men after a 2012 recommendation that all men should not be routinely screened for prostate cancer, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/Le6LYLj7DgI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 17 Nov 2015 13:01:34 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151117130134.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151117130134.htm</feedburner:origLink></item>
		<item>
			<title>Small RNA has big impact on prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/6HWJq7bVGoc/151117093203.htm</link>
			<description>microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer, new research concludes. This small RNA fragment hit multiple targets, reducing androgen receptor signaling and reviving the potency of enzalutamide, a treatment for advanced prostate cancer. In addition, miR-124 impeded EZH2 and Src, proteins that contribute to treatment resistance.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/6HWJq7bVGoc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 17 Nov 2015 09:32:03 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151117093203.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151117093203.htm</feedburner:origLink></item>
		<item>
			<title>Prostate cancer screening under age of 55 may be of limited value</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/rHarr1ZSXt8/151114185056.htm</link>
			<description>Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after the age of 55, according to a new 20 year analysis of 6822 patients.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/rHarr1ZSXt8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sat, 14 Nov 2015 18:50:56 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151114185056.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151114185056.htm</feedburner:origLink></item>
		<item>
			<title>New test for prostate cancer significantly improves prostate cancer screening</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/SSeucfBuMiU/151109220027.htm</link>
			<description>A new study shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. The new test, which has undergone trial in 58,818 men, discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/SSeucfBuMiU" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151109220027.jpg" height="214" width="300" />
			<pubDate>Mon, 09 Nov 2015 22:00:27 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151109220027.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151109220027.htm</feedburner:origLink></item>
		<item>
			<title>Blood test picks out prostate cancer drug resistance</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/Q0MffbLCUvA/151104151521.htm</link>
			<description>Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment. The new research paves the way for information from a blood test to inform prostate cancer treatment in future, with only those patients whose cancers are free of resistance mutations taking the drug, abiraterone.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/Q0MffbLCUvA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 04 Nov 2015 15:15:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151104151521.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151104151521.htm</feedburner:origLink></item>
		<item>
			<title>Wide variation found in costs to treat low-risk prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/CWv37kicKsQ/151102164105.htm</link>
			<description>Researchers have described cost across an entire care process for low-risk prostate cancer -- from the time a patient checks in for his first appointment to his post-treatment follow-up testing -- using time-driven activity-based costing.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/CWv37kicKsQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 02 Nov 2015 16:41:05 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151102164105.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151102164105.htm</feedburner:origLink></item>
		<item>
			<title>Scientists show how frequently mutated prostate cancer gene suppresses tumors</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/BNZP70BfX0E/151029134109.htm</link>
			<description>New research has found how SPOP, a gene frequently mutated in prostate cancer, is able to halt tumors by inducing senescence, a state of stable cell cycle arrest, which means that the cells have stopped dividing and growing. With this new information, scientists may be able to design therapeutic strategies that can halt cancers caused by these mutated genes that are able to bypass senescence.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/BNZP70BfX0E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 29 Oct 2015 13:41:09 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151029134109.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151029134109.htm</feedburner:origLink></item>
		<item>
			<title>New genetic discovery advances understanding of prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/G2r279rnQlg/151026132318.htm</link>
			<description>A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team. Prostate cancer is one of the most common cancers affecting men.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/G2r279rnQlg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 26 Oct 2015 13:23:18 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151026132318.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151026132318.htm</feedburner:origLink></item>
		<item>
			<title>Racial differences in outcomes, costs of care in older men with prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/nitAUXPs1G0/151022124528.htm</link>
			<description>Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs and have worse postoperative outcomes than white men but that did not translate to worse overall or cancer-specific survival, according to an article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/nitAUXPs1G0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 22 Oct 2015 12:45:28 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151022124528.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151022124528.htm</feedburner:origLink></item>
		<item>
			<title>The dilemma of screening for prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/scf4ybdEesA/151014132404.htm</link>
			<description>Primary care providers are put in a difficult position when screening their male patients for prostate cancer -- some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients. Now a new perspective piece offers some guidance on when to screen patients and how to involve them in decisions about screening and treatment.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/scf4ybdEesA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 14 Oct 2015 13:24:04 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151014132404.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151014132404.htm</feedburner:origLink></item>
		<item>
			<title>Prostate cells undergo 'reprogramming' to form tumors, study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/6oz2OHHSgs4/151012115707.htm</link>
			<description>Researchers link early prostate cancer to alterations in a program controlled by a 'master regulator' of cell growth. These epigenetic changes point to new avenues for preventing and treating prostate cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/6oz2OHHSgs4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 12 Oct 2015 11:57:07 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151012115707.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151012115707.htm</feedburner:origLink></item>
		<item>
			<title>Novel compound turns off mutant cancer gene in animals with leukemia</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/teJfFCMxnMk/151009102038.htm</link>
			<description>A compound that halts cancer in animals with Ewing sarcoma and prostate cancer appears to work against some forms of leukemia, too, scientists report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/teJfFCMxnMk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 09 Oct 2015 10:20:38 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151009102038.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151009102038.htm</feedburner:origLink></item>
		<item>
			<title>Testosterone therapy does not increase aggressive prostate cancer risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/lPgcmEjsCfA/151005132737.htm</link>
			<description>Exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer, shows a new population-based study. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/lPgcmEjsCfA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 05 Oct 2015 13:27:37 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151005132737.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151005132737.htm</feedburner:origLink></item>
		<item>
			<title>Better evaluation of prostate cancer MRI-scans</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/O_EnjECl844/151001095805.htm</link>
			<description>International radiological bodies have agreed on a standard for how doctors evaluate MRI to confirm a diagnosis of prostate cancer. This promises to reduce the number of over diagnosis of insignificant cancers by to up to 89%. The new procedure also allows radiologists to identify up to 13% more life-threatening tumors than current procedures.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/O_EnjECl844" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 01 Oct 2015 09:58:05 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151001095805.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151001095805.htm</feedburner:origLink></item>
		<item>
			<title>Risk factors for prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/HCNoy7N4pAA/150929230115.htm</link>
			<description>New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk. In contrast, obesity, alcohol abuse, and smoking show a negative association with the disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/HCNoy7N4pAA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 29 Sep 2015 23:01:15 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150929230115.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150929230115.htm</feedburner:origLink></item>
		<item>
			<title>Fewer, larger radiotherapy doses prove effective for prostate cancer patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/gsKzSl9bYHo/150928082416.htm</link>
			<description>Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research. The results could mean men need fewer trips to hospital â over four weeks rather than seven and a half â without reducing the quality and impact of their prostate cancer treatment.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/gsKzSl9bYHo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 28 Sep 2015 08:24:16 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150928082416.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150928082416.htm</feedburner:origLink></item>
		<item>
			<title>Androgen deprivation therapy associated with increased risk for fatal heart attack</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/bGr4z02LVXk/150922114743.htm</link>
			<description>Long term follow up of a randomized clinical trial that compared ADT and radiation therapy (RT) to RT alone finds that men with significant comorbidity; most commonly prior heart attack, who received ADT died earlier, due to a fatal heart attack, compared to men who did not receive ADT.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/bGr4z02LVXk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 22 Sep 2015 11:47:43 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150922114743.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150922114743.htm</feedburner:origLink></item>
		<item>
			<title>More men at risk for prostate cancer as a result of less regular screening</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/FyW9gl4OIMQ/150922103956.htm</link>
			<description>The US Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate and high risk cancer diagnoses raises concern because of the potential for delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/FyW9gl4OIMQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 22 Sep 2015 10:39:56 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150922103956.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150922103956.htm</feedburner:origLink></item>
		<item>
			<title>Becoming cyborgs in the battle against prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/_PNdw7RWWQY/150921112733.htm</link>
			<description>Men are surprisingly positive and open to the concept of having cancer-detecting biosensors implanted within their bodies â effectively making them cyborgs -- new research suggests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/_PNdw7RWWQY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 21 Sep 2015 11:27:33 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150921112733.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150921112733.htm</feedburner:origLink></item>
		<item>
			<title>Molecular imaging study reveals improved detection of early recurrent prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/-b3UopsxlDQ/150917135223.htm</link>
			<description>A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, researchers report. The American Cancer Society reports that prostate cancer is the second leading cause of cancer death in American men, behind lung cancer, with about 220,800 new cases estimated in 2015.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/-b3UopsxlDQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Sep 2015 13:52:23 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150917135223.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150917135223.htm</feedburner:origLink></item>
		<item>
			<title>New catalyst yields more accurate PSA test</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/xFN6-jhdlLg/150916125512.htm</link>
			<description>Chemists have developed a catalyst that improves the sensitivity of the standard PSA test over 100-fold. The catalyst is made of palladium nanocubes coated with iridium.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/xFN6-jhdlLg" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/09/150916125512.jpg" height="135" width="300" />
			<pubDate>Wed, 16 Sep 2015 12:55:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150916125512.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150916125512.htm</feedburner:origLink></item>
		<item>
			<title>How the 'heat' compound from chili peppers could help kill cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/T0Keb3u0usE/150909125003.htm</link>
			<description>Capsaicin, the compound responsible for chilis' heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/T0Keb3u0usE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 09 Sep 2015 12:50:03 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150909125003.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150909125003.htm</feedburner:origLink></item>
		<item>
			<title>Some with low-risk prostate cancer not likely to succumb to the disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/LjyXU6c9G3k/150831163741.htm</link>
			<description>Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study that analyzed survival statistics up to 15 years.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/LjyXU6c9G3k" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 31 Aug 2015 16:37:41 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150831163741.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150831163741.htm</feedburner:origLink></item>
		<item>
			<title>Adverse effects of common prostate enlargement and hair growth drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/ryEN7sxCHm4/150825155819.htm</link>
			<description>Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement, appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/ryEN7sxCHm4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 25 Aug 2015 15:58:19 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150825155819.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150825155819.htm</feedburner:origLink></item>
		<item>
			<title>Two-drug combination boosts survival in metastatic prostate cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/prostate_health/~3/DKRqH6F6wdo/150805191905.htm</link>
			<description>Men with metastatic, hormone-sensitive prostate cancer gained more than a year of survival when they received both hormone-blocking medications and chemotherapy right after diagnosis, rather than delaying the chemo until the cancer worsened, according to a study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/prostate_health/~4/DKRqH6F6wdo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 05 Aug 2015 19:19:05 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150805191905.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150805191905.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 22:37:01 EST -->
